65 related articles for article (PubMed ID: 22130024)
1. [RXR, a key member of the oncogenic complex in acute promyelocytic leukemia].
Halftermeyer J; Le Bras M; De Thé H
Med Sci (Paris); 2011 Nov; 27(11):973-8. PubMed ID: 22130024
[TBL] [Abstract][Full Text] [Related]
2. RXR is an essential component of the oncogenic PML/RARA complex in vivo.
Zhu J; Nasr R; Pérès L; Riaucoux-Lormière F; Honoré N; Berthier C; Kamashev D; Zhou J; Vitoux D; Lavau C; de Thé H
Cancer Cell; 2007 Jul; 12(1):23-35. PubMed ID: 17613434
[TBL] [Abstract][Full Text] [Related]
3. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
4. RARA fusion genes in acute promyelocytic leukemia: a review.
De Braekeleer E; Douet-Guilbert N; De Braekeleer M
Expert Rev Hematol; 2014 Jun; 7(3):347-57. PubMed ID: 24720386
[TBL] [Abstract][Full Text] [Related]
5. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
[TBL] [Abstract][Full Text] [Related]
6. Determinants of oncogenic transformation in acute promyelocytic leukemia: the hetero-union makes the force.
Minucci S; Pelicci PG
Cancer Cell; 2007 Jul; 12(1):1-3. PubMed ID: 17613430
[TBL] [Abstract][Full Text] [Related]
7. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
8. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
9. Autophagic degradation of an oncoprotein.
Bøe SO; Simonsen A
Autophagy; 2010 Oct; 6(7):964-5. PubMed ID: 20724820
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
[TBL] [Abstract][Full Text] [Related]
11. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
13. PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.
Martens JH; Brinkman AB; Simmer F; Francoijs KJ; Nebbioso A; Ferrara F; Altucci L; Stunnenberg HG
Cancer Cell; 2010 Feb; 17(2):173-85. PubMed ID: 20159609
[TBL] [Abstract][Full Text] [Related]
14. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
Mozziconacci MJ; Rosenauer A; Restouin A; Fanelli M; Shao W; Fernandez F; Toiron Y; Viscardi J; Gambacorti-Passerini C; Miller WH; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 2002 Nov; 35(3):261-70. PubMed ID: 12353268
[TBL] [Abstract][Full Text] [Related]
16. [Retinoic acid receptor alpha gene in t (15; 17) APL].
Takashima T; Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1363-8. PubMed ID: 1325570
[TBL] [Abstract][Full Text] [Related]
17. Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.
Qiu JJ; Lu X; Zeisig BB; Ma Z; Cai X; Chen S; Gronemeyer H; Tweardy DJ; So CW; Dong S
Blood; 2010 Jan; 115(3):643-52. PubMed ID: 19965660
[TBL] [Abstract][Full Text] [Related]
18. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.
Zhou J; Pérès L; Honoré N; Nasr R; Zhu J; de Thé H
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9238-43. PubMed ID: 16757557
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
Yang WC; Shih HM
Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
[TBL] [Abstract][Full Text] [Related]
20. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]